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RESEARCH ARTICLE  
PREVALENCE OF STAPHYLOCOCCUS AUREUS IN DENTAL INFECTIONS AND THE 
OCCURRENCE OF MRSA IN ISOLATES 
 
ABSTRACT 
  Background and aims:  Staphylococcus  aureus is an opportunist that causes dental infection and systemic 
infections in the human body. This organism increases its resistance to many types of antibiotics every day and 
becomes more resistant, and this led to a growing feeling of concern in this era. Given this fact, the aims of this 
study were to determine the frequency of Staph.aureus in oral infections and to determine the prevalence of 
MRSA strains and the sensitivity of isolated Staph.aureus to antibiotics, in patients who attended dental clinics 
in major public hospitals and private clinics in the city of Sana'a - Yemen. 
Subjects and methods: The study was conducted for a year, starting in December 2018 and ending in 
November 2019. The study included 296 patients, 153 male and 143 female, ages 5 to 65, with an average age of 
36.2 years. Clinical and demographic data were collected in the standard questionnaire, then oral swabs or pus 
were collected from patients, cultivated, isolated and identified using standard laboratory techniques. MRSA was 
determined by means of the disc diffusion method to 5 micrograms of methycillin disc and 1 micrograms of 
oxicillin disc; an antimicrobial sensitivity test was performed by means of disc diffusion method of selected 
antibiotics.The oral  infections include  dental abscesses,  periodontal abscesses, gingivitis, periodentitis, dental 
caries,  pulpitis and oral thrush.  
Results: Of a total of 296 cultured swabs, only 217 swabs produced a positive culture (73.3%). Gram-positive 
bacteria formed 67.4% of the total isolates where Staph. aureus was the predominant pathogen (43.1%).  The 
prevalence of MRSA was 23.5%. There was a higher rate of antibiotic resistance tested in MRSA isolates 
compared to a lower rate of resistance in MSSA as well as 22.2% of MRSA isolates were vancomycin resistant, 
while only 11.4% of MSSA were vancomycin resistant. 
Conclusion:  It can be concluded, Staph.aureus was the most common bacterial isolate in dental infections,  
high rate of  MRSA,  the emergence of Staph.aureus isolates resistant to vancomycin and other wide range of 
antibiotics have raised MRSA in oral infections into a multi-drug-resistant, making it more and more dangerous 
in oral infections. Regular surveillance of oral associated infections and monitoring antibiotic sensitivity pattern 
and strict drug policy for antibiotics are recommend. 
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INTRODUCTION 
The human oral cavity acts as a growth medium for pathogenic microorganisms due to its moisture, temperature, 
and nutritional content such as fats, carbohydrates, and protein1. There are several types of dental infections that 
occur in the patient's oral cavity such as periodontal disease,  tooth  decay,  dental ache, dental plaque, dental 
abscess, dentin hypersensitivity, dental calculus, hyperdontia, malocclusion, acid erosion, ulcerative  gingivitis, 
acute necrotizing,  dental  fluorosis,  tooth impaction, etc. Staph.aureus is a presumed pathogen for many oral 
diseases, such as oral mucositis, periodontitis, peri-implantitis,  endodontic  infections and even  dental caries 2-5. 
    Staph.aureus is  a  Gram-positive,  non-spore forming,  non-motile, grape   like   clusters and the most   
important coagulase  positive  pathogen  from  staphylococci  due  to mixture  of  invasiveness, toxic  mediated  
virulence and antibiotic resistance 6. Some Staph.aureus strains have developed drug-resistant7. Methicillin-
resistant Staph.aureus (MRSA)8 are the strains of Staph.aureus that have been resistant to beta-lactam 
antibiotics, which include penicillins, amoxicillin, ampicillin, methicillin, oxacillin, cephalosporins, etc.9. The 
tendency of Staph.aureus to acquire antibiotic resistance led to a global dissemination  of  clone  expressing 
various antimicrobial resistances. Many bacterial diseases occur in hospitals and in community  due to MRSA 
strains and sometimes   lead   to death 10-12. 
Staph.aureus infection, including MRSA strains, has long been common in Yemen13. Because the indiscriminate 
use of antibiotics is a typical practice, hospital environments are not clean enough and crowding of patients and 
health workers supports the spread of infectious germs including Staph.aureus 13. The potential presence of 
Staph.aureus is especially important in dental infections due to its increased resistance13,14. Therefore it is very 
logical to check the status of the microbial resistance against the commonly used antibiotics for the treatment of 
dental infections that occur by Staph.aureus. Considering this ,  the aims of this study were to determine the 
frequency of of Staph.aureus in oral infections and to  identify the prevalence of MRSA strains and antibiotic 
sensitivity of isolated Staph.aureus, in patients attended  the dental clinics at the main general hospitals and 
private clinics in Sana’a city-Yemen. 
PATIENTS, MATERIALS AND METHODS 
Patients: The study was conducted for a year, beginning in December 2018 and ending in November 2019. The 
 
 
study included 296 patients, 153 male and 143 female, ages 5 to 65, with an average age of 36.2 years. Clinical 
and demographic data were collected in the standard questionnaire, then oral swabs or pus were collected from 
patients, cultivated, isolated and identified using standard laboratory techniques. The oral  infections include  
dental abscesses,  periodontal abscesses, gingivitis, periodentitis, dental caries,  pulpitis and oral thrush. 
Cases definition: All patients enrolled in this study, who had a major complaint of various oral infections and 
entered dental clinics in the city of Sana'a.  
Data collection and processing: A questionnaire was filled out for each patient with the patient's personal and 
clinical data. This included age, gender, profession and relevant clinical information regarding bacterial and 
fungal oral infections. Upon initial hospitalization, cultures were obtained from the oral infection sites in order to 
isolate the causative agents of various bacteria and fungi. 
Antimicrobial susceptibility test:  Antibiotic resistance phenotypes (Methicillin / Oxacillin sensitivity test): All 
isolates of Staph.aureus were tested for the susceptibility to 5 μg Methicillin disc and 1 μg Oxacillin disc 
provided by Difco using the disk diffusion method as described by NCCLS. The resistance breakpoints were ≥14 
mm to ≤ 10 mm for 5 μg Methicillin, and ≥ 12 mm to ≤ 10 mm for 1 μg Oxacillin. The ability of other antibiotic 
disc to inhibit MRSA or MSSA were estimated according to the guidelines provided by NCCLS using 
commercially available discs which include: Augmenitin (AC 30 µg), tetracycline (T,30 µg), erythromycin(E,15 
µg), ceftizoxime (CEF 20 µg ), ciprofloxacin(Ci 5 µg), clindamycin(CC, 2 µg), clarithromycin (Cl 15 µg)  and 
vancomycin(V, 30 µg).  The zone of inhibition produced by Staph. aureus against each antibiotic was  measured 
 and  interpreted  as  resistant and  susceptible  according  to  standards  of  Clinical  Laboratory  and Standards 
Institute15.   
RESULTS 
The positive culture rate was 73.3% and 26.7% of the specimens were negative (table 1). A hundred and eighty 
180 (67.4%) were Gram positive bacteria, 71 (26.6%) were Gram negative bacteria and 16 (6.0%) were 
C.albicans. The most frequent microorganism isolated was Staph.aureus (115 isolates), followed by Bacteroides 
spp (71 isolates) and Strept. pyogens (38 isolates) with percentages of 43.1%, 26.6% and 14.2% respectively.  
Table 3shows the susceptibility patterns of Staph.aureus isolates towards the different commonly used 
antibiotics. The resistant results for MRSA of antibiotics represented in number and percentages are shown in 
the following order: vancomycin (22.2%), clindamycin (26%), ciprofloxacin (29.7%), ceftizoxime (40.7%), 
calrithromycin (37%), augmentin (55.6%), tetracycline (74%), and erythromycin (23.3%). The resistant results 
for MSSA of antibiotics represented in number and percentages are shown in the following order: vancomycin 
(11.4%), clindamycin (30.3%), ciprofloxacin (22.7%), ceftizoxime (30.3%), calrithromycin (26.3%), augmentin 
(30.7%), tetracycline (72.7%), and erythromycin (60.2%). 
DISCUSSION 
Dental patients typically take antibiotics primarily to treat postoperative and secondary infections. In the current 
study all 115 coagulase positive isolates of Staph.aureus were subjected to disc diffusion method to 5 μg 
Methicillin disc and 1 μg Oxacillin disc to determine MRSA; the  test  results  discovered that  23.5% of isolated 
Staph.aureus were MRSA strain. The current rate of 23.5% of MRSA in all isolates of Staph.aureus is lower 
than the rate reported from Yemen in previous reports in which MRSA was isolated from 55% of health workers 
in Taiz, Yemen16, also it is very lower than that reported by al-Baidani and others, 17 among health care workers 
in Al Hodeida City, Yemen where the MRSA rate was 86%. On the other hand, it was almost similar to that 
mentioned by Al-Safani et al. 13 (19.3%) among patients attending Military Hospital, Sana'a City; and  Alyahawi, 
and others among patients of some private hospitals in Sana’a City (17.6%),18. 
   HA-MRSA occurred at a higher rate than CA-MRSA in the world, but in Yemen the rates were similar for the 
HA-MRSA and CA-MRSA (19.4% and 17%, respectively), as mentioned by Al-Safani et al.13 and Alyahawi et 
al. 18. This result can be explained by long hospitalization, random use of antibiotics, lack of awareness, and 
receiving antibiotics before coming to hospital, which are some of the potential predisposing factors for the 
appearance of MRSA in the hospital and community. Our result differs from that reported in the United States of 
America where a high incidence of MRSA occurred in a hospital-acquired Staph.aureus infection (HA-MRSA) 
(59%), compared to a community-acquired infection of  Staph.aureus (17%) [19]. This difference can be 
explained by the CA-MRSA biology appearing to be different from the HA-MRSA and the MSSA, which may 
allow CA-MRSA to cause diseases other than those expected from MSSA20,21. 
   With the advent of HA-MRSA, it is likely that it not only replaced HA-MSSA, but also led to a comprehensive 
increase in Staph.aureus infection in healthcare settings 22,23. In addition, almost all researchers say the same 
thing that inpatients and outpatients suffer from Staph.aureus / MRSA infection higher than Staph.aureus / 
MSSA due to the widespread prevalence of MRSA in a community environment and hospitals 23-25. When 
comparing our MRSA rate with the MRSA rate in Staph.aureus dental infections, our result (23.5%) was almost 
lower than the 30% MRSA reported by Das Manisha  et al. 26.   Also ,the prevalence of MRSA (23.5%) was 
 
 
higher than the results of Ayepola et al. 27 who reported 2.4%, as well as Smith et al. [28] 6% of MRSA positive 
isolates were reported in oral infection. Another study by Renvert et al. 29 in Sweden, observed similar results 
associated with periodontitis patients. 
According to  Kurita   et al. 30 dental patients are not the only ones responsible for spreading MRSA bacteria, but 
a health professional may transfer this pathogen through their tools, so there are consistent guidelines for 
controlling MRSA as the CDC some standard precautions may be recommended which may help reduce the 
prevalence of MRSA among dental patients 31.  
The reason for conducting the current study was to know the prevalence of MRSA and the current antimicrobial 
profile of Staph.aureus in order to choose the appropriate empirical treatment for these oral infections.  In our 
study, vancomycin resistance (VRSA) was 22.2% in isolated MRSA. This result differs from that reported in 
Asian countries where the vancomycin resistance rate was no more than 10% 32. The occurrence of VRSA in 
Asian countries has also been documented by Kaleem et al. 33 in Pakistan to be 3.3%, 6% in India, by Sonavane 
and Mathur,34, 7.5% in Iran by Mehdinejad et al. 35 and 9% in Jordan are from Al-Zoubi and others36. The 
current study results  revealed  that  73% dental Staph.aureus isolates were found resistant to tetercycline 
followed by 53.9% to   erythromycin,   46.5%   to augmanten,   and   35.6%   to Cefotaxime where low rates of 
resistant occurred for ciprofloxacin (24.3%), Clarithromycin (28.7%), and  Clindamycin (29.6%) (Table 3).  
Kim  and  Lee37  and Das Manisha  et al. 26 reported  more sensitive strains of Staph.aureus isolated   from   the 
periodontal patients   showed sensitivity  95% to ciprofloxacin (vs 75.7%) and 90% to tetracycline (vs 31%), 
90% to  erythromycin (vs 46.1%), and to 3rd generation cephalosporins 95% (vs 62.4%)   that  is  comparatively 
higher  than the current  study.  Similar  antimicrobial  susceptibility  results were reported by previous authors  
8,38-40. The  higher  resistant  rates in Yemen  to  commonly  used  antibiotics indicates  indiscriminate or  
haphazard  use that may have effect  on  treatment cost,  poor   prognosis as   well  as enhance  the   bacterial   
infection   and   growth   virulent  pathogens.  
CONCLUSION   
Prevalence of Staph.aureus in  dental  patients is quite  high and  showed  resistance to  commonly  used  
antibiotics  as well as carried high rate of MRSA. Despite these results,  the  sample size  of  this  study  is  not  
sufficient  and  study  period  was too  short  to uncover actual  picture  of  MRSA  involved  in dental infection 
in Sana’a city, Yemen.  Large scale studies could be done both in hospitalized patients and in community   to 
identify   prevalence   of MRSA,   genome analysis,  identification  of  toxin  gene  and  other  antibiotic resistant 
gene. Regular brushing of teeth, keeping up oral cleanliness  and  consulting with  dental  doctors  to  check up 
the teeth once in a month should be taken to maintain a distance from dental infections.  
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Table 1: Cultural results of the 296 patients with bacterial and fungal oral infections. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Results 
 
No. 
 
% 
 
 
Positive cultures 
 
217 
 
73.3 
 
Negative cultures 
 
79 
 
26.7 
 
 
Total 
 
296 
 
100 
 
 
 
Table 2: Distribution of the 217 positive culture isolates according to their group and genus. 
 
 
Isolates 
 
 
No. 
 
% 
 
Gram positive bacteria 
 
 
180 
 
 
67.4 
Staph. aureus 
Strept. pyogenes 
Staph. epidermidis 
Strept. mutans  
115 
38 
16 
11 
43.1 
14.2 
6.0 
4.1 
 
Gram negative bacteria 
 
 
71 
 
26.6 
Bacteroides spp 
 
71          26.6 
Yeasts 
 
16 6.0 
Candida albicans 
 
16 6.0 
 
Total 
 
267 100.0 
 
 
  
Table 3: The antibiotic sensitivity for 115 isolated  MRSA and MSSA for tested antibiotics. 
 
 
Antibiotics 
MRSA  
n=27 (23.5%) 
MSSA  
n=88 (76.5%) 
Sensitive Resistant  Sensitive  Resistant 
Augmentin 12 (44.4%) 15 (55.6%) 61 (69.3%) 27 (30.7%) 
Cefotaxime 11 (40.7%) 16 (59.3%) 61(69.3%) 27 (30.3%) 
Ciprofloxacin 19 (70.3%) 8 (29.7%) 68 (77.3%) 20 (22.7%) 
Clarithromycin 17 (63%) 10 (37%) 65 (73.7%) 23 (26.3%) 
Clindamycin 20 (74%) 7 (26%) 61(69.3%) 27 (30.3%) 
Erythromycin 18 (66.7%) 9 (23.3%) 35 (39.8%) 53 (60.2%) 
Tetracycline  7 (26%) 20 (74%) 24 (27.3%) 64 (72.7%) 
Vancomycin  21(77.8%) 6 (22.2%) 37 (42%) 51 (58%) 
 
 
